Effect of the host cell line on the vaccine efficacy of an attenuated porcine reproductive and respiratory syndrome virus

Veterinary Immunology and Immunopathology

Volumn 148, Issue 1-2, 2012, Pages 116-125

  Calzada Nova, Gabriela ^a   Husmann, Robert J ^a   Schnitzlein, William M ^a   Zuckermann, Federico A ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Aptimmune Biologics Inc   (United States)

Author keywords

Adaptation; Attenuated virus; Cell line; Efficacy; Host cell; Macrophage; PRRSV; Vaccine; Viremia; ZMAC cells

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN 2; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIVIRUS; ARTERIVIRUS INFECTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISTRESS SYNDROME; HOST CELL; IMMUNIZATION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PROTEIN GLYCOSYLATION; VIREMIA; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; IMMUNIZATION; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; VACCINES, ATTENUATED; VIRAL LOAD; VIRAL VACCINES; VIREMIA;

ANIMALIA; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SIMIAE; SUIDAE; SUS;

EID: 84864126195     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.05.008     Document Type: Article

References (59)

1. APHIS, 2009. PRRS Seroprevalences on U.S. swine operations. USDA-APHIS-VS, CEAH, Fort Collins, CO. January.
2. Butler J.E., Lemke C.D., Weber P., Sinkora M., Lager K.M. Antibody repertoire development in fetal and neonatal piglets: XIX. Undiversified B cells with hydrophobic HCDR3s preferentially proliferate in the porcine reproductive and respiratory syndrome. J. Immunol. 2007, 10:6320-6331.
3. Calvert J.G., Slade D.E., Shields S.L., Jolie R., Mannan R.M., Ankenbauer R.G., Welch S.K. CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses. J. Virol. 2007, 14:7371-7379.
4. Calzada-Nova G., Schnitzlein W.M., Husmann R.J., Zuckermann F.A. North American porcine reproductive and respiratory syndrome viruses inhibit type I interferon production by plasmacytoid dendritic cells. J. Virol. 2011, 6:2703-2713.
5. Chang C.C., Yoon K.J., Zimmerman J.J., Harmon K.M., Dixon P.M., Dvorak C.M., Murtaugh M.P. Evolution of porcine reproductive and respiratory syndrome virus during sequential passages in pigs. J. Virol. 2002, 76:4750-4763.
6. Cho J.G., Dee S.A., Deen J., Guedes A., Trincado C., Fano E., Jiang Y., Faaberg K., Collins J.E., Murtaugh M.P., Joo H.S. Evaluation of the effects of animal age, concurrent bacterial infection, and pathogenicity of porcine reproductive and respiratory syndrome virus on virus concentration in pigs. Am. J. Vet. Res. 2006, 3:489-493.
7. Corzo C.A., Mondaca E., Wayne S., Torremorell M., Dee S., Davies P., Morrison R.B. Control and elimination of porcine reproductive and respiratory syndrome virus. Virus Res. 2010, 154:185-192.
8. Darwich L., Diaz I., Mateu E. Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology. Virus Res. 2010, 154:123-132.
9. Das P.B., Dinh P.X., Ansari I.H., de Lima M., Osorio F.A., Pattnaik A.K. The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J. Virol. 2010, 84:1731-1740.
10. Das P.B., Vu H.L., Dinh P.X., Cooney J.L., Kwon B., Osorio F.A., Pattnaik A.K. Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response. Virology 2011, 2:385-394.
11. Delrue I., Van Gorp H., Van Doorsselaere J., Delputte P., Nauwynck H. Susceptible cell lines for the production of porcine reproductive and respiratory syndrome virus by stable transfection of sialoadhesin and CD163. BMC Biotechnol. 2010, 1:48.
12. Duan X., Nauwynck H.J., Pensaert M.B. Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV). Arch. Virol. 1997, 12:2483-2497.
13. Duan X., Nauwynck H.J., Pensaert M.B. Virus quantification and identification of cellular targets in the lungs and lymphoid tissues of pigs at different time intervals after inoculation with porcine reproductive and respiratory syndrome virus (PRRSV). Vet. Microbiol. 1997, 56:9-19.
14. Ellingson J.S., Wang Y., Layton S., Ciacci-Zanella J., Roof M.B., Faaberg K.S. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras. Vaccine 2010, 28:2679-2686.
15. Goldberg T.L., Lowe J.F., Milburn S.M., Firkins L.D. Quasispecies variation of porcine reproductive and respiratory syndrome virus during natural infection. Virology 2003, 317:197-207.
16. Greiner L.L., Stahly T.S., Stabel T.J. Quantitative relationship of systemic virus concentration on growth and immune response in pigs. J. Anim. Sci. 2000, 10:2690-2695.
17. Halbur P.G. Factors that influence the severity of clinical disease. PRRS Compendium 2003, 17-25. National Pork Board, Iowa. J.J. Zimmermann, K.J. Yoon (Eds.).
18. Harms P.A., Sorden S.D., Halbur P.G., Bolin S.R., Lager K.M., Morozov I., Paul P.S. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus. Vet. Pathol. 2001, 38:528-539.
19. Huang Y.W., Meng X.J. Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV). Virus Res. 2010, 154:141-149.
20. Jung K., Renukaradhya G.J., Alekseev K.P., Fang Y., Tang Y., Saif L.J. Porcine reproductive and respiratory syndrome virus modifies innate immunity and alters disease outcome in pigs subsequently infected with porcine respiratory coronavirus: implications for respiratory viral co-infections. J. Gen. Virol. 2009, 90:2713-2723.
21. Kwon B., Ansari I.H., Osorio F.A., Pattnaik A.K. Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model. Vaccine 2006, 24:7071-7080.
22. Labarque G., Van Gucht S., Van Reeth K., Nauwynck H., Pensaert M. Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines. Vet. Microbiol. 2003, 95:187-197.
23. Lamontagne L., Page C., Larochelle R., Longtin D., Magar R. Polyclonal activation of B cells occurs in lymphoid organs from porcine reproductive and respiratory syndrome virus (PRRSV)-infected pigs. Vet. Immunol. Immunopathol. 2001, 82:165-182.
24. Lawson S., Lunney J., Zuckermann F., Osorio F., Nelson E., Welbon C., Clement T., Fang Y., Wong S., Kulas K., Christopher-Hennings J. Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination. Vaccine 2010, 32:5356-5364.
25. Lee Y.J., Park C., Nam E., Kim S., Lee O., Lee D.S., Lee C. Generation of a porcine alveolar macrophage cell line for the growth of porcine reproductive and respiratory syndrome virus. J. Virol. Methods 2010, 2:410-415.
26. Lowe J.F., Zuckermann F.A., Firkins L.D., Schnitzlein W.M., Goldberg T.L. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions. J. Am. Vet. Med. Assoc. 2006, 7:1082-1088.
27. Lunney J.K., Benfield D.A., Rowland R.R. Porcine reproductive and respiratory syndrome virus: an update on an emerging and re-emerging viral disease of swine. Virus Res. 2010, 154:1-6.
28. Meier W.A., Galeota J., Osorio F.A., Husmann R.J., Schnitzlein W.M., Zuckermann F.A. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 2003, 1:18-31.
29. Meier W.A., Husmann R.J., Schnitzlein W.M., Osorio F.A., Lunney J.K., Zuckermann F.A. Cytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2004, 102:299-314.
30. Mengeling W.L., Lager K.M., Vorwald A.C. The effect of porcine parvovirus and porcine reproductive and respiratory syndrome virus on porcine reproductive performance. Anim. Reprod. Sci. 2000, 60-61:199-210.
31. Mengeling W.L., Lager K.M., Vorwald A.C., Koehler K.J. Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 2003, 1:13-24.
32. Mengeling W.L., Vorwald A.C., Lager K.M., Brockmeier S.L. Comparison among strains of porcine reproductive and respiratory syndrome virus for their ability to cause reproductive failure. Am. J. Vet. Res. 1996, 6:834-839.
33. Murtaugh M.P., Stadejek T., Abrahante J.E., Lam T.T., Leung F.C. The ever-expanding diversity of porcine reproductive and respiratory syndrome virus. Virus Res. 2010, 154:18-30.
34. Murtaugh M.P., Xiao Z., Zuckermann F. Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol. 2002, 4:533-547.
35. Nielsen H.S., Oleksiewicz M.B., Forsberg R., Stadejek T., Botner A., Storgaard T. Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J. Gen. Virol. 2001, 82:1263-1272.
36. Nielsen J., Botner A., Bille-Hansen V., Oleksiewicz M.B., Storgaard T. Experimental inoculation of late term pregnant sows with a field isolate of porcine reproductive and respiratory syndrome vaccine-derived virus. Vet. Microbiol. 2002, 84:1-13.
37. Okuda Y., Kuroda M., Ono M., Chikata S., Shibata I. Efficacy of vaccination with porcine reproductive and respiratory syndrome virus following challenges with field isolates in Japan. J. Vet. Med. Sci. 2008, 70:1017-1025.
38. Opriessnig T., Baker R.B., Halbur P.G. Use of an experimental model to test the efficacy of planned exposure to live porcine reproductive and respiratory syndrome virus. Clin. Vaccine Immunol. 2007, 14:1572-1577.
39. Opriessnig T., Halbur P.G., Yoon K.J., Pogranichniy R.M., Harmon K.M., Evans R., Key K.F., Pallares F.J., Thomas P., Meng X.J. Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV. J. Virol. 2002, 23:11837-11844.
40. Ostrowski M., Galeota J.A., Jar A.M., Platt K.B., Osorio F.A., Lopez O.J. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 2002, 9:4241-4250.
41. Plagemann P.G., Rowland R.R., Faaberg K.S. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch. Virol. 2002, 12:2327-2347.
42. Ramakrishnan M.A., Tu Z.J., Singh S., Chockalingam A.K., Gramer M.R., Wang P., Goyal S.M., Yang M., Halvorson D.A., Sreevatsan S. The feasibility of using high resolution genome sequencing of influenza A viruses to detect mixed infections and quasispecies. PLoS ONE 2009, 4:e7105.
43. Rossow K.D. Porcine reproductive and respiratory syndrome. Vet. Pathol. 1998, 1:1-20.
44. Rowland R.R.R., Steffen M., Ackerman T., Benfield D.A. The evolution of porcine reproductive and respiratory syndrome virus: quasispecies and emergence of a virus subpopulation during infection of pigs with VR-2332. Virology 1999, 259:262-266.
45. Royaee A.R., Husmann R.J., Dawson H.D., Calzada-Nova G., Schnitzlein W.M., Zuckermann F.A., Lunney J.K. Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination. Vet. Immunol. Immunopathol. 2004, 3:199-216.
46. Schwarzer J., Rapp E., Hennig R., Genzel Y., Jordan I., Sandig V., Reichl U. Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine 2009, 32:4325-4336.
47. Tan F., Wei Z., Li Y., Zhang R., Zhuang J., Sun Z., Yuan S. Identification of non-essential regions in nucleocapsid protein of porcine reproductive and respiratory syndrome virus for replication in cell culture. Virus Res. 2011, 158:62-71.
48. Tian Z.J., An T.Q., Zhou Y.J., Peng J.M., Hu S.P., Wei T.C., Jiang Y.F., Xiao Y., Tong G.Z. An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS. Vet. Microbiol. 2009, 138:34-40.
49. Torremorell M., Christianson W.T. PRRS eradication by herd closure. Adv. Pork Prod. 2002, 169-176.
50. USDA, 2008. Part IV. Changes in the U.S. Pork Industry, 1990-2006. USDA-APHIS-VS, CEAH. Fort Collins, CO. #N520.1108.
51. Vanhee M., Delputte P.L., Delrue I., Geldhof M.F., Nauwynck H.J. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies. Vet. Res. 2009, 40:63-77.
52. Van Reeth K., Nauwynck H. Proinflammatory cytokines and viral respiratory disease in pigs. Vet. Res. 2000, 2:187-213.
53. Vashisht K., Erlandson K.R., Firkins L.D., Zuckermann F.A., Goldberg T.L. Evaluation of contact exposure as a method for acclimatizing growing pigs to porcine reproductive and respiratory syndrome virus. J. Am. Vet. Med. Assoc. 2008, 10:1530-1535.
54. Wang C., Wu B., Amer S., Luo J., Zhang H., Guo Y., Dong G., Zhao B., He H. Phylogenetic analysis and molecular characteristics of seven variant Chinese field isolates of PRRSV. BMC Microbiol. 2010, 10:146-156.
55. Weingartl H.M., Sabara M., Pasick J., van Moorlehem E., Babiuk L. Continuous porcine cell lines developed from alveolar macrophages: partial characterization and virus susceptibility. J. Virol. Methods 2002, 2:203-216.
56. Wissink E.H., Kroese M.V., Maneschijn-Bonsing J.G., Meulenberg J.J., van Rijn P.A., Rijsewijk F.A., Rottier P.J. Significance of the oligosaccharides of the porcine reproductive and respiratory syndrome virus glycoproteins GP2a and GP5 for infectious virus production. J. Gen. Virol. 2004, 85:3715-3723.
57. Zhou Y.J., Hao X.F., Tian Z.J., Tong G.Z., Yoo D., An T.Q., Zhou T., Li G.X., Qiu H.J., Wei T.C., Yuan X.F. Highly virulent porcine reproductive and respiratory syndrome virus emerged in China. Transbound Emerg. Dis. 2008, 55:152-164.
58. Zimmerman J.J., Benfield D.A., Murtaugh M.P., Osorio F.A., Stevenson G.W., Torremorell M. Porcine reproductive and respiratory syndrome virus (Porcine Arterivirus). Diseases of Swine 2006, 387-416. Blackwell Publishing, Iowa. B.A. Straw, J.J. Zimmerman, S. D'Allaire, D.J. Taylor (Eds.).
59. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., Osorio F. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet. Microbiol. 2007, 123:69-85.